Ha Il-Soo, Yap Hui K, Munarriz Reyner L, Zambrano Pedro H, Flynn Joseph T, Bilge Ilmay, Szczepanska Maria, Lai Wai-Ming, Antonio Zenaida L, Gulati Ashima, Hooman Nakysa, van Hoeck Koen, Higuita Lina M S, Verrina Enrico, Klaus Günter, Fischbach Michel, Riyami Mohammed A, Sahpazova Emilja, Sander Anja, Warady Bradley A, Schaefer Franz
Kidney Center for Children and Adolescents, Seoul National University Children's Hospital, Seoul, Korea.
Shaw-NKF-NUH Children's Kidney Centre, The Children's Medical Institute, Singapore.
Kidney Int. 2015 Sep;88(3):605-13. doi: 10.1038/ki.2015.108. Epub 2015 Apr 15.
In dialyzed patients, preservation of residual renal function is associated with better survival, lower morbidity, and greater quality of life. To analyze the evolution of residual diuresis over time, we prospectively monitored urine output in 401 pediatric patients in the global IPPN registry who commenced peritoneal dialysis (PD) with significant residual renal function. Associations of patient characteristics and time-variant covariates with daily urine output and the risk of developing oligoanuria (under 100 ml/m(2)/day) were analyzed by mixed linear modeling and Cox regression analysis including time-varying covariates. With an average loss of daily urine volume of 130 ml/m(2) per year, median time to oligoanuria was 48 months. Residual diuresis significantly subsided more rapidly in children with glomerulopathies, lower diuresis at start of PD, high ultrafiltration volume, and icodextrin use. Administration of diuretics significantly reduced oligoanuria risk, whereas the prescription of renin-angiotensin system antagonists significantly increased the risk oligoanuria. Urine output on PD was significantly associated in a negative manner with glomerulopathies (-584 ml/m(2)) and marginally with the use of icodextrin (-179 ml/m(2)) but positively associated with the use of biocompatible PD fluid (+111 ml/m(2)). Children in both Asia and North America had consistently lower urine output compared with those in Europe perhaps due to regional variances in therapy. Thus, in children undergoing PD, residual renal function depends strongly on the cause of underlying kidney disease and may be modifiable by diuretic therapy, peritoneal ultrafiltration, and choice of PD fluid.
在透析患者中,保留残余肾功能与更好的生存率、更低的发病率和更高的生活质量相关。为了分析残余尿量随时间的变化情况,我们前瞻性地监测了全球IPPN登记处401例开始腹膜透析(PD)且具有显著残余肾功能的儿科患者的尿量。通过混合线性模型和包括时变协变量的Cox回归分析,分析了患者特征和时变协变量与每日尿量以及发生少尿(低于100 ml/m²/天)风险之间的关联。每年平均尿量损失130 ml/m²,少尿的中位时间为48个月。在患有肾小球疾病、PD开始时尿量较低、超滤量高以及使用艾考糊精的儿童中,残余尿量显著下降得更快。使用利尿剂显著降低了少尿风险,而肾素 - 血管紧张素系统拮抗剂的处方显著增加了少尿风险。PD时的尿量与肾小球疾病呈显著负相关(-584 ml/m²),与艾考糊精的使用呈微弱负相关(-179 ml/m²),但与生物相容性PD液的使用呈正相关(+111 ml/m²)。与欧洲儿童相比,亚洲和北美的儿童尿量一直较低,这可能是由于治疗的地区差异所致。因此,在接受PD的儿童中,残余肾功能很大程度上取决于潜在肾脏疾病的病因,并且可能通过利尿剂治疗、腹膜超滤和PD液的选择来改变。